EGOI-PCOS survey on the prevalence of respiratory disorders associated with polycystic ovary syndrome

Mario Montanino Oliva; Maurizio Nordio; Orietta Picconi; Giuseppina Porcaro

doi:10.5826/mrm.2025.1051

EGOI-PCOS survey on the prevalence of respiratory disorders associated with polycystic ovary syndrome

Authors

Mario Montanino Oliva Department of Obstetrics and Gynecology, Santo Spirito Hospital, Rome, Italy; The Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, Italy
Maurizio Nordio Department of Experimental Medicine, Sapienza University, Rome, Italy; The Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, Italy
Orietta Picconi National HIV/AIDS Research Center (CNAIDS), Istituto Superiore di Sanità, Rome, Italy
Giuseppina Porcaro Clinica Sotherga, Milan, Italy; The Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, Italy

DOI: https://doi.org/10.5826/mrm.2025.1051

Keywords:

asthma, menstrual disturbances, chronic respiratory disease, Polycystic ovarian syndrome, PCOS

Abstract

Background: Polycystic Ovary Syndrome (PCOS) is a multifaceted disorder that has also recently been associated with chronic respiratory diseases (CRDs). While several studies have highlighted that pulmonary health is frequently altered in women with PCOS and vice versa, no mechanistic investigation has elucidated an overlapped etiology, so far. Thus, in the present survey we explored the frequency of respiratory issues in a population of PCOS patients, and the medical characteristics that possibly link the two diseases.
Results: A total of 353 women participated in the survey. CRDs affected 27.4% of the surveyed PCOS patients, with asthma representing the most prevalent respiratory problem in 61.5% of cases. In 59.3% of women, respiratory and PCOS onset appaired at the same age and in 68% of cases first symptoms appeared in adolescence.
Conclusions: While several authors have linked respiratory issues and menstrual disturbances, there are no available surveys that investigate the frequency of CRDs in PCOS patients. Despite their qualitative nature, our results sustain previous indications on a possible link between CRDs and PCOS. In future, appropriate studies may elucidate possible etiological mechanisms joining respiratory health to PCOS.

References

1. Unfer V, Kandaraki E, Pkhaladze L, Roseff S, Vazquez-Levin MH, Laganà AS, et al. When one size does not fit all: reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments. Endocr Metab Sci 2024;14:100159.

2. Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H, Dokaneheifard S, et al. Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Arch Gynecol Obstet 2024;310:1303-14.

3. Carriero VC, Forte G, Dinicola S, Oliva MM, Mudarris GA, Unfer V. Insights from the EGOI-PCOS patient survey: diagnosis, treatment, and quality of life according to Italian PCOS patients. Eur J Obstet Gynecol Reprod Biol 2025;310:113947.

4. Facchinetti F, Gambineri A, Aimaretti G, Ferlin A, Lagana AS, Moghetti P, et al. Delphi consensus on the diagnostic criteria of polycystic ovary syndrome. J Endocrinol Invest 2025;48(6):1293-1302.

5. Myers SH, Forte G, Unfer V. Has the name PCOS run its course? Arch Gynecol Obstet 2024;310:1761-2.

6. Htet TD, Teede HJ, de Courten B, Loxton D, Real FG, Moran LJ, et al. Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity. European Respiratory Journal 2017;49:1601334.

7. Han MK, Shteinberg M, Assayag D, Schleich F, Pengo M, Scicluna VM, et al. Respiratory Diseases in Women. Arch Bronconeumol 2024;61:290-8.

8. Akashanand, Nazli KM, Kumar BA, R. R, Mandeep K, Manish S, et al. Patterns and trends in burden of asthma and its attributable risk factors from 1990 to 2021 among South Asian countries: a systematic analysis for the Global Burden of Disease Study 2021. J Asthma 2025;62:1020-31.

9. Pinkerton JV, Guico-Pabia CJ, Taylor HS. Menstrual cycle-related exacerbation of disease. Am J Obstet Gynecol 2010;202:221-31.

10. Ghiasi M, Chang C, Shafrir AL, Vitonis AF, Sasamoto N, Vazquez AI, et al. Subgroups of pelvic pain are differentially associated with endometriosis and inflammatory comorbidities: a latent class analysis. Pain 2024;165:2119-29.

11. Jin C, Dharmage S, Dobson A, Mishra GD. Menstrual disorders and the risk of asthma: a prospective study of women from their early twenties to their mid-forties. Maturitas 2025;195:108218.

12. Al-Beltagi M, Bediwy AS, Saeed NK, Bediwy HA, Elbeltagi R. Diabetes-inducing effects of bronchial asthma. World J Diabetes 2025;16:97954.

13. Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol 2021;95:531-41.

14. Guarnieri G, Iervolino M, Cavallone S, Unfer V, Vianello A. The “asthma-polycystic ovary overlap syndrome” and the therapeutic role of myo-Inositol. Int J Mol Sci 2023;24:6959.

15. Action for the pulmonary health in Italy: International Respiratory Coalition; 2021 [Available from: https://international-respiratory-coalition.org/countries/italy/it/].

16. Underdal MO, Salvesen Ø, Henriksen AH, Andersen M, Vanky E. Impaired respiratory function in women with PCOS compared with matched controls from a population-based study. J Clin Endocrinol Metab 2020;105:344-54.

17. Yang Y, Gong T, Camargo CA, Valdimarsdóttir UA, Bertone-Johnson E, Lu D. Childhood asthma, allergies and risk of premenstrual disorders in young adulthood. Nat Ment Health 2023;1:410-9.

18. Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. J Clin Endocrinol Metab 2015;100:911-9.

19. Rosen ED, Kajimura S. Is it time to rethink the relationship between adipose inflammation and insulin resistance? J Clin Invest 2024;134:e184663.

20. Grieger JA, Hodge A, Mishra G, Joham AE, Moran LJ. The association between dietary intake, asthma, and PCOS in women from the australian longitudinal study on women’s health. J Clin Med 2020;9:233.

21. Seims A, White A. The State of Men’s Health in Leeds: Data Report. Leeds: Leeds Beckett University and Leeds City Council; 2016.

22. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1211-59.

23. Juber NF, Abdulle A, AlJunaibi A, AlNaeemi A, Ahmad A, Leinberger-Jabari A, et al. Association between pediatric asthma and adult polycystic ovarian syndrome (PCOS): a cross-sectional analysis of the UAE healthy future Study (UAEHFS). Front Endocrinol (Lausanne) 2023;14:1022272.

24. Reddy KD, Oliver BGG. Sexual dimorphism in chronic respiratory diseases. Cell Biosci 2023;13:47.

25. Zein JG, Erzurum SC. Asthma is Different in Women. Curr Allergy Asthma Rep 2015;15:28.

26. Barr RG, Wentowski CC, Grodstein F, Somers SC, Stampfer MJ, Schwartz J, et al. Prospective Study of Postmenopausal Hormone Use and Newly Diagnosed Asthma and Chronic Obstructive Pulmonary Disease. Arch Intern Med 2004;164:379-86.

27. Tam A, Morrish D, Wadsworth S, Dorscheid D, Man SF, Sin DD. The role of female hormones on lung function in chronic lung diseases. BMC Womens Health 2011;11:24.

28. Xu Y, Zhou ZY, Pan JX, Huang HF. Associations between asthma and polycystic ovary syndrome: current perspectives. Front Endocrinol (Lausanne) 2022;13:936948.

29. Amisi CA. Markers of insulin resistance in Polycystic ovary syndrome women: An update. World J Diabetes 2022;13:129-49.

30. Myers SH, Soulage CO, Unfer V. Endocrine metabolic syndrome and metabolic syndrome: distinct but interrelated pathologies. Gynecol Obstet Invest 2025;20:1-11.

31. Bartziokas K, Papaioannou AI, Drakopanagiotakis F, Gouveri E, Papanas N, Steiropoulos P. Unraveling the link between insulin resistance and bronchial asthma. Biomedicines 2024;12:437.

32. Dinicola S, Unfer V, Facchinetti F, Soulage CO, Greene ND, Bizzarri M, et al. Inositols: From Established Knowledge to Novel Approaches. Int J Mol Sci 2021;22(19):10575.

33. Gambioli R, Forte G, Buzzaccarini G, Unfer V, Lagana AS. Myo-Inositol as a Key Supporter of Fertility and Physiological Gestation. Pharmaceuticals (Basel) 2021;14.

34. Greff D, Juhasz AE, Vancsa S, Varadi A, Sipos Z, Szinte J, et al. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol 2023;21:10.

35. Hallman M, Bry K, Hoppu K, Lappi M, Pohjavuori M. Inositol supplementation in premature infants with respiratory distress syndrome. N Engl J Med 1992;326:1233-9.

36. Chroneos ZC, Sever-Chroneos Z, Shepherd VL. Pulmonary surfactant: an immunological perspective. Cell Physiol Biochem 2010;25:13-26.

37. Spiga A. Nebulized myo-inositol increases oxygen saturation and relieves symptoms in patients with airways diseases. Int J Med Device Adjuvant Treat 2021; 4 : e356.

38. Li JM, Chang WH, Li L, Yang DC, Hsu SW, Kenyon NJ, et al. Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis. Respir Res 2023;24:132.

39. Li JM, Yang DC, Oldham J, Linderholm A, Zhang J, Liu J, et al. Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosis. Mol Ther 2021;29:1487-500.